Dietary reference intakes for macronutrients
On this page
- Reference values for Carbohydrate (Digestible), Total Protein, Total Fat, Linoleic Acid (n-6), α-linolenic Acid (n-3), Total Fibre, and Total Water
- Acceptable Macronutrient Distribution Ranges (AMDRs)
Age | Carbohydrate (Digestible) |
Total ProteinTable 1 footnote 30 | Total Fat | Linoleic Acid (n-6) |
α-linolenic Acid (n-3) |
Total FibreTable 1 footnote 32 | Total WaterTable 1 footnote 34 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EAR g/day |
RDA/AI g/day |
ULTable 1 footnote 29 g/day |
EAR g/kg/day |
RDA/AI g/kg/day |
RDA/AI g/day Table 1 footnote 31 |
ULTable 1 footnote 29 g/day Table 1 footnote 31 |
AI g/day |
ULTable 1 footnote 29 g/day |
AI g/day |
ULTable 1 footnote 29 g/day |
AI g/day |
ULTable 1 footnote 29 g/day |
AITable 1 footnote 33 g/day |
ULTable 1 footnote 29 g/day |
AI Litres/day |
ULTable 1 footnote 29 Litres/day |
|
Infants | |||||||||||||||||
0–6 mo | ND | 60Table 1 footnote * | ND | ND | 1.52Table 1 footnote * | 9.1Table 1 footnote * | ND | 31Table 1 footnote * | ND | 4.4Table 1 footnote * | ND | 0.5Table 1 footnote * | ND | ND | ND | 0.7Table 1 footnote * | ND |
7–12 mo | ND | 95Table 1 footnote * | ND | 1.0 | 1.2 | 11.0 | ND | 30Table 1 footnote * | ND | 4.6Table 1 footnote * | ND | 0.5Table 1 footnote * | ND | ND | ND | 0.8Table 1 footnote * | ND |
Children | |||||||||||||||||
1–3 y | 100 | 130 | ND | 0.87 | 1.05 | 13 | ND | ND | ND | 7Table 1 footnote * | ND | 0.7Table 1 footnote * | ND | 19Table 1 footnote * | ND | 1.3Table 1 footnote * | ND |
4–8 y | 100 | 130 | ND | 0.76 | 0.95 | 19 | ND | ND | ND | 10Table 1 footnote * | ND | 0.9Table 1 footnote * | ND | 25Table 1 footnote * | ND | 1.7Table 1 footnote * | ND |
Males | |||||||||||||||||
9–13 y | 100 | 130 | ND | 0.76 | 0.95 | 34 | ND | ND | ND | 12Table 1 footnote * | ND | 1.2Table 1 footnote * | ND | 31Table 1 footnote * | ND | 2.4Table 1 footnote * | ND |
14–18 y | 100 | 130 | ND | 0.73 | 0.85 | 52 | ND | ND | ND | 16Table 1 footnote * | ND | 1.6Table 1 footnote * | ND | 38Table 1 footnote * | ND | 3.3Table 1 footnote * | ND |
19–30 y | 100 | 130 | ND | 0.66 | 0.80 | 56 | ND | ND | ND | 17Table 1 footnote * | ND | 1.6Table 1 footnote * | ND | 38Table 1 footnote * | ND | 3.7Table 1 footnote * | ND |
31–50 y | 100 | 130 | ND | 0.66 | 0.80 | 56 | ND | ND | ND | 17Table 1 footnote * | ND | 1.6Table 1 footnote * | ND | 38Table 1 footnote * | ND | 3.7Table 1 footnote * | ND |
51–70 y | 100 | 130 | ND | 0.66 | 0.80 | 56 | ND | ND | ND | 14Table 1 footnote * | ND | 1.6Table 1 footnote * | ND | 30Table 1 footnote * | ND | 3.7Table 1 footnote * | ND |
>70 y | 100 | 130 | ND | 0.66 | 0.80 | 56 | ND | ND | ND | 14Table 1 footnote * | ND | 1.6Table 1 footnote * | ND | 30Table 1 footnote * | ND | 3.7Table 1 footnote * | ND |
Females | |||||||||||||||||
9–13 y | 100 | 130 | ND | 0.76 | 0.95 | 34 | ND | ND | ND | 10Table 1 footnote * | ND | 1.0Table 1 footnote * | ND | 26Table 1 footnote * | ND | 2.1Table 1 footnote * | ND |
14–18 y | 100 | 130 | ND | 0.71 | 0.85 | 46 | ND | ND | ND | 11Table 1 footnote * | ND | 1.1Table 1 footnote * | ND | 26Table 1 footnote * | ND | 2.3Table 1 footnote * | ND |
19–30 y | 100 | 130 | ND | 0.66 | 0.80 | 46 | ND | ND | ND | 12Table 1 footnote * | ND | 1.1Table 1 footnote * | ND | 25Table 1 footnote * | ND | 2.7Table 1 footnote * | ND |
31–50 y | 100 | 130 | ND | 0.66 | 0.80 | 46 | ND | ND | ND | 12Table 1 footnote * | ND | 1.1Table 1 footnote * | ND | 25Table 1 footnote * | ND | 2.7Table 1 footnote * | ND |
51–70 y | 100 | 130 | ND | 0.66 | 0.80 | 46 | ND | ND | ND | 11Table 1 footnote * | ND | 1.1Table 1 footnote * | ND | 21Table 1 footnote * | ND | 2.7Table 1 footnote * | ND |
>70 y | 100 | 130 | ND | 0.66 | 0.80 | 46 | ND | ND | ND | 11Table 1 footnote * | ND | 1.1Table 1 footnote * | ND | 21Table 1 footnote * | ND | 2.7Table 1 footnote * | ND |
Pregnancy | |||||||||||||||||
≤ 18 y | 135 | 175 | ND | 0.88Table 1 footnote i | 1.1Table 1 footnote i | 71Table 1 footnote i | ND | ND | ND | 13Table 1 footnote * | ND | 1.4Table 1 footnote * | ND | 28Table 1 footnote * | ND | 3.0Table 1 footnote * | ND |
19–30 y | 135 | 175 | ND | 0.88Table 1 footnote i | 1.1Table 1 footnote i | 71Table 1 footnote i | ND | ND | ND | 13Table 1 footnote * | ND | 1.4Table 1 footnote * | ND | 28Table 1 footnote * | ND | 3.0Table 1 footnote * | ND |
31–50 y | 135 | 175 | ND | 0.88Table 1 footnote i | 1.1Table 1 footnote i | 71Table 1 footnote i | ND | ND | ND | 13Table 1 footnote * | ND | 1.4Table 1 footnote * | ND | 28Table 1 footnote * | ND | 3.0Table 1 footnote * | ND |
Lactation | |||||||||||||||||
≤ 18 y | 160 | 210 | ND | 1.05 | 1.3 | 71 | ND | ND | ND | 13Table 1 footnote * | ND | 1.3Table 1 footnote * | ND | 29Table 1 footnote * | ND | 3.8Table 1 footnote * | ND |
19–30 y | 160 | 210 | ND | 1.05 | 1.3 | 71 | ND | ND | ND | 13Table 1 footnote * | ND | 1.3Table 1 footnote * | ND | 29Table 1 footnote * | ND | 3.8Table 1 footnote * | ND |
31–50 y | 160 | 210 | ND | 1.05 | 1.3 | 71 | ND | ND | ND | 13Table 1 footnote * | ND | 1.3Table 1 footnote * | ND | 29Table 1 footnote * | ND | 3.8Table 1 footnote * | ND |
Note: These are reference values for normal, apparently healthy individuals eating a typical mixed North American diet. An individual may have physiological, health, or lifestyle characteristics that may require tailoring of specific nutrient values. |
Males & Females Tableau 2 note de bas de page 35 | Total Carbohydrate Percent of Energy |
Total Protein Percent of Energy |
Total Fat Percent of Energy |
n-6 polyunsaturated fatty acids (linoleic acid) Percent of Energy |
n-3 polyunsaturated fatty acids (α-linolenic acid) Percent of EnergyTableau 2 note de bas de page 36 |
---|---|---|---|---|---|
1–3 years | 45–65% | 5–20% | 30–40% | 5–10% | 0.6–1.2% |
4–18 years | 45–65% | 10–30% | 25–35% | 5–10% | 0.6–1.2% |
19 years and over | 45–65% | 10–35% | 20–35% | 5–10% | 0.6–1.2% |
Page details
- Date modified: